ARCHIVES

ImClone Protocol Generates More Questions Than Answers.

This article is from The Cancer Letter archive.

Vol. 28 No. 07 | February 15, 2002

Download PDF Visit The Full Archive

Related Articles

In Brief : Patricia LoRusso Named Associate Director Of Innovative Medicine at Yale Cancer Center

June 20, 2014

Oral Complications Reduced By Pretherapy NIH Conference Finds

April 28, 1989

ODAC Votes Against Cell Therapeutics Agent; Requires ChemGenex To Develop Diagnostic.

April 9, 2010

Abstracts of ‘Most Newsworthy’ Papers

June 3, 1977

Coalition Opens Web Site To Promote Cancer Trials.

June 15, 2001

Clinical Trials Approved By NCI CTEP Last Month

January 28, 2011